Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Edgewise Therapeutics Inc (EWTX)

Edgewise Therapeutics Inc (EWTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Edgewise Therapeutics Inc 1715 38TH ST BOULDER CO 80301 USA

www.edgewisetx.com Employees: 146 P: 720-262-7002

Sector:

Medical

Description:

Edgewise Therapeutics Inc. is a clinical-stage biopharmaceutical company. It is focused on developing orally bioavailable, small molecule therapies for rare muscle disorders. Edgewise Therapeutics Inc. is based in Boulder, United States.

Key Statistics

Overview:

Market Capitalization, $K 3,379,037
Enterprise Value, $K 3,317,887
Shares Outstanding, K 107,271
Float, K 82,384
% Float 76.80%
Short Interest, K 9,475
Short Float 8.83%
Days to Cover 9.89
Short Volume Ratio 0.47
% of Insider Shareholders 23.20%

Financials:

Annual Sales, $ 0 K
Annual Net Income, $ -167,800 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -50,220 K
EBIT, $ -191,410 K
EBITDA, $ -196,810 K

Growth:

1-Year Return 64.63%
3-Year Return 417.81%
5-Year Return 12.19%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.47 on 02/26/26
Next Earnings Date 05/14/26
Earnings Per Share ttm -1.63
EPS Growth vs. Prev Qtr -20.51%
EPS Growth vs. Prev Year -11.90%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%

EWTX Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -31.97%
Return-on-Assets % -30.46%
Profit Margin % 0.00%
Debt/Equity 0.00
Price/Sales N/A
Price/Cash Flow N/A
Price/Book 6.14
Book Value/Share 4.93
Interest Coverage -3.19
60-Month Beta 0.26
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.